← Open Payments lookup

CEYDA ORS: Open Payments

NPI 1497288625 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,587 in 76 payments from 15 companies in 2025. Trend: 2023 $774 · 2024 $2,352 · 2025 $1,587

Food & beverage: $1,504Education: $83
CompanyPaymentsAmount
SUN PHARMACEUTICAL INDUSTRIES INC.15$375
PFIZER INC.9$297
LEO Pharma Inc.14$230
GENZYME CORPORATION9$184
Arcutis Biotherapeutics, Inc.11$138
Almirall LLC3$71
Organon LLC3$54
Medimetriks Pharmaceuticals, Inc.3$47
Galderma Laboratories, L.P.2$38
Novartis Pharmaceuticals Corporation1$32

Products named: DUPIXENT, ADBRY, CIBINQO, ILUMYA, Zoryve, LITFULO, Winlevi, Seysara.

Industry payments across TX — which companies pay providers there.